You are here

Opzelura

Incyte's JAK cream Opzelura picks up steam as company works to revive Jakafi XR dreams

Fierce Pharma

Mon, 02/10/25 - 10:27 pm

Incyte plots Delaware expansion as it looks to re-wed commercial, medical teams in its home state

Fierce Pharma

Tue, 05/21/24 - 06:56 pm

Incyte reports positive data from Phase III vitiligo trial

Clinical Trials Arena

Thu, 10/12/23 - 05:27 pm

clinical trials

Despite recent progress, Incyte still far off from pricing goal for key eczema launch Opzelura

Fierce Pharma

Tue, 11/1/22 - 06:59 pm

FDA Action Alert: Incyte, Arcutis Await Decisions in Vitiligo, Psoriasis

BioSpace

Mon, 07/18/22 - 10:22 am

Arcutis Biotherapeutics

Incyte's Opzelura slapped with vitiligo delay amid topical JAK's eczema launch

Fierce Pharma

Mon, 03/14/22 - 11:37 pm

FDA sets April date for verdict on Incyte’s vitiligo drug

Pharmaforum

Wed, 12/15/21 - 10:43 am